F&P Healthcare lifts profit forecast

MICHAEL FOREMAN
Last updated 15:04 20/08/2014

Relevant offers

Industries

Air New Zealand pulls in-flight Jaguar ad Veritas in talks with several parties but disputes Constellation store's actions Trade Me to help address youth unemployment in Auckland Cos Bruyn leaves Downer for Fulton Hogan New broadband plan drives down cost of data Construction starts on Auckland's next luxury apartment complex Amazon angers India with Gandhi jandals and flag doormat Hellaby concedes in takeover battle Stronger competition for workers could push up pay, forecasts ASB Completion of trans-Tasman cable delayed until March after mishap

A weaker New Zealand dollar has prompted medical device manufacturer Fisher & Paykel Healthcare to raise its profit forecast for the next financial year to $100 million.

In May, when the kiwi was hovering at 86 cents to the United States dollar, the company forecast a net profit of $97m for the year to March.

But at the company's annual shareholder meeting in Auckland this afternoon, chief executive Michael Daniell said the forecast had been raised by $3m, based on an exchange rate of 84c to the US dollar.

He said revenue growth so far this year had been "robust", thanks to a growing acceptance by clinicians and healthcare providers of F&P's respiratory care systems and products for the treatment of obstructive sleep apnoea.

"We released a broad range of new products in the last year and we have a substantial pipeline in development, with a large number of exciting new products to be introduced over the next 12 to 18 months," Daniell said.

At current exchange rates, the company said, it expected operating revenue for the first half of the financial year to be about $315m and net profit to be about $45m.

Assuming an exchange rate of 84c to the US dollar for the rest of the year, the company said, full-year operating revenue was now expected to be about $650m.

Ad Feedback

- Stuff

Special offers

Featured Promotions

Sponsored Content